Royal Bank Of Canada Valneva Se Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.64 - $10.76 $13 - $21	-2 Reduced 10.0%	18 $0
Q4 2022 Feb 14, 2023	SELL	$10.38 - $14.87 $20 - $29	-2 Reduced 9.09%	20 $0
Q3 2022 Nov 14, 2022	SELL	$9.8 - $23.35 $215 - $513	-22 Reduced 50.0%	22 $0
Q2 2022 Aug 15, 2022	BUY	$13.71 - $37.57 $603 - $1,653	44 New	44 $1,000
Q1 2022 May 16, 2022	SELL	$27.0 - $50.99 $594 - $1,121	-22 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$27.1 - $67.28 $596 - $1,480	22 New	22 $1,000

4.52M

Ticker VALN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,103,504
Market Cap $612M
Description
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.